SLC9A3 and cystic fibrosis: The NHE3 inhibitor tenapanor improved gastrointestinal transport in CF mice by targeting inhibition of sodium absorption348, indicating that inhibition of GCC signal transduction and NHE3 may be a suitable target for the treatment of constipation in patients with CF.